effect overlay
activetrials
Epilepsy
Epilepsy
Biscayne2

Evaluation of Safety and Efficacy of BIS-001ER for the Treatment of Adult Focal Impaired Awareness Seizures (FIAS)
 

HREC: 2017.373
Principal Investigator: Dr John-Paul Nicolo
Coordinator contact: Sean Hosking
Funding: Non-Commercial
Epilepsy
Epilepsy
PHARMACOGENOMICS

PGx Identifying genetic and molecular biomarkers of epilepsy and the response to treatment
 

HREC: 2017.450
Principal Investigator: Prof Terry O'Brien
Coordinator contact: Dr Marian Todaro
Funding: Non-Commercial
Epilepsy
Epilepsy
GREP Study

Clinical utility and cost-effectiveness of immediate vs delayed genome sequencing for refractory epilepsy in children and adults: a multicentre randomised controlled trial
 

HREC: 2018.052
Principal Investigator: Prof Patrick Kwan
Coordinator contact: Dr Marian Todaro
Funding: Non-Commercial
Epilepsy
Epilepsy
VNS Registry

CORE VNS: Comprehensive Outcomes Registry in Subjects with Epilepsy Treated with Vagus Nerve Stimulation Therapy®
 

HREC: 2018.175
Principal Investigator: Dr John-Paul Nicolo
Coordinator contact: Sean Hosking
Funding: Commercial
Epilepsy
Epilepsy
RETT - Anavex 002

A Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Study of ANAVEX2-73 in Patients with Rett Syndrome
 

HREC: 2018.394
Principal Investigator: Prof Patrick Kwan
Coordinator contact: Sean Hosking
Funding: Commercial